News archive

NCRI Seeking chairperson, workstream leads and members for a new academic pathology working group (CM-Path)

The NCRI Cellular Molecular Pathology (CM-Path) initiative aims to improve diagnosis and treatment of cancer patients by breathing new life into academic cell and tissue-based pathology. It will provide strategic co-ordination of research training, basic and translational research opportunities and implementation of new approaches in pathology for faster innovation in cancer care.
The CM-Path initiative will bring together a working group of experts from pathology and other disciplines to make advances in four main areas:
Skills and capacity – to enhance academic opportunities and promote continuous up-skilling of the cellular pathology workforce.
Clinical trials – to encourage profession-wide engagement of pathologists with clinical trials and associated research.
Discovery – to focus on boosting activities in ‘hub’ centres of excellence, where pathologists have roles in investigating the biology of cancer and its treatments.
Technology and information – to promote continuous innovation in cellular molecular pathology and pathology informatics.

Who should apply?
Individuals appointed to the chair and workstream lead positions are expected to be experienced cellular pathologists with an academic track record and strong leadership skills.
Workstream membership will be open to pathologists of all levels of seniority who are engaged with research, including trainees at all stages. We also invite applications from academics in other specialties who feel they can contribute to make to delivery of the workstream objectives.
The advertised roles are open to applicants from all areas of the UK and we hope to achieve representation across a broad range of institutions.